Pfizer agreed to lower prescription drug costs for Medicaid and invest $70 billion in US manufacturing, President Trump announced. This deal includes most-favoured-nation pricing for Medicaid, aiming to significantly reduce healthcare expenses. Pfizer’s shares surged following the announcement, which precedes new US tariffs on branded drugs.Pfizer agreed to lower prescription drug costs for Medicaid and invest $70 billion in US manufacturing, President Trump announced. This deal includes most-favoured-nation pricing for Medicaid, aiming to significantly reduce healthcare expenses. Pfizer’s shares surged following the announcement, which precedes new US tariffs on branded drugs.
